Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06880627 · ClinicalTrials.gov registry record · NA
Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis
A NA study of Scleroderma, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT06880627: Recruiting NA study of Scleroderma, sponsored by University of Michigan.
NCT06880627 is a NA study of Scleroderma that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 66 participants, below the 400-participant average among 23 other Scleroderma trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06880627, a NA study of Scleroderma, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements immediately after treatment at week 8 in all cognitive function measures, non-cognitive symptoms, and self-management compared to those in the waitlist control.
Primary Outcome
This will be assessed using the online platform BrainCheck. The following tests will be included: (1) Trail Making A \& B (attention and mental flexibility); (2) Stroop Color and Word test (executive function); (3) Digit-Symbol Substitution (processing speed); and (4) Immediate and Delayed Recognition tests (memory). A composite score will be calculated through BrainCheck to assess global cognitive function. The score range is 0-200 a higher score means greater cognitive function.
Conditions Studied
Interventions
- BEHAVIORAL Brain Boost group
- OTHER Waitlist group
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2025-04-16 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06880627 shows while recruiting
NCT06880627 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 400-participant average among 23 other Scleroderma trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Scleroderma appearing as the primary indexed condition, and to 2 interventions - of which Brain Boost group is the first listed.
NCT06880627 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06880627 about?
NCT06880627 is a clinical study titled "Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis". The purpose of this study is to examine whether an 8-week online educational group-based program tailored to people with systemic sclerosis can help improve cognitive function and well-being. The study team hypothesize that participants that receive the intervention will have better improvements im...
What is the current status of trial NCT06880627?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-04-16. Estimated completion is 2027-06.
What conditions does trial NCT06880627 study?
This clinical trial studies the following conditions: Scleroderma.
What interventions are being tested in trial NCT06880627?
The interventions under investigation include: Brain Boost group (BEHAVIORAL), Waitlist group (OTHER).
Who is sponsoring clinical trial NCT06880627?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06880627 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scleroderma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06880627's enrollment target sits among peer trials
66 14th of 23 higher than 9 of 23 other Scleroderma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Scleroderma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma
COMPLETED · NA
-
RENEW-AI: Personalizing Scleroderma Management With an AI Health Coach
COMPLETED · NA
-
Rheumatology Diet Study
RECRUITING
-
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
RECRUITING
-
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RECRUITING · Phase 1
-
Platform Clinical Study for Conquering Scleroderma
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI